ALG8 | GeneID:854233 | Saccharomyces cerevisiae
Gene Summary
[
] NCBI Entrez Gene
| Gene ID | 854233 | Official Symbol | ALG8 |
|---|---|---|---|
| Locus | YOR067C | Gene Type | protein-coding |
| Synonyms | YOR29-18 | ||
| Full Name | N/A | ||
| Description | Alg8p | ||
| Chromosome | N/A | ||
| Also Known As | Glucosyl transferase, involved in N-linked glycosylation; adds glucose to the dolichol-linked oligosaccharide precursor prior to transfer to protein during lipid-linked oligosaccharide biosynthesis; similar to Alg6p | ||
| Summary | N/A | ||
Orthologs and Paralogs
[
] Homologs - NCBI's HomoloGene Group: 6931
| ID | Symbol | Protein | Species |
|---|---|---|---|
| GeneID:31623 | CG4542 | NP_572355.1 | Drosophila melanogaster |
| GeneID:79053 | ALG8 | NP_076984.2 | Homo sapiens |
| GeneID:174542 | glucosyltransferase | NP_001021940.1 | Caenorhabditis elegans |
| GeneID:293129 | Alg8 | NP_001029299.1 | Rattus norvegicus |
| GeneID:327601 | alg8 | NP_001017647.1 | Danio rerio |
| GeneID:381903 | Alg8 | NP_950200.1 | Mus musculus |
| GeneID:428097 | ALG8 | XP_425656.2 | Gallus gallus |
| GeneID:451446 | ALG8 | XP_508663.2 | Pan troglodytes |
| GeneID:476793 | ALG8 | XP_533998.2 | Canis lupus familiaris |
| GeneID:538731 | ALG8 | NP_001069593.1 | Bos taurus |
| GeneID:819074 | AT2G44660 | NP_181994.1 | Arabidopsis thaliana |
| GeneID:854233 | ALG8 | NP_014710.1 | Saccharomyces cerevisiae |
| GeneID:1278755 | AgaP_AGAP003928 | XP_318380.2 | Anopheles gambiae |
| GeneID:2542143 | alg8 | NP_594599.1 | Schizosaccharomyces pombe |
| GeneID:2675944 | MGG_05686 | XP_360312.2 | Magnaporthe grisea |
| GeneID:2704462 | NCU00163.1 | XP_322249.1 | Neurospora crassa |
| GeneID:2895645 | KLLA0F16621g | XP_455827.1 | Kluyveromyces lactis |
| GeneID:4330363 | Os02g0688500 | NP_001047779.1 | Oryza sativa |
| GeneID:4620468 | AGOS_ADR210C | NP_984306.1 | Eremothecium gossypii |
Gene Classification
[
] Gene Ontology
| ID | Category | GO Term |
|---|---|---|
| GO:0005783 | Component | endoplasmic reticulum |
| GO:0005789 | Component | endoplasmic reticulum membrane |
| GO:0016021 | Component | integral to membrane |
| GO:0016020 | Component | membrane |
| GO:0042283 | Function | dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase activity |
| GO:0016740 | Function | transferase activity |
| GO:0016757 | Function | transferase activity, transferring glycosyl groups |
| GO:0016758 | Function | transferase activity, transferring hexosyl groups |
| GO:0043094 | Process | cellular metabolic compound salvage |
| GO:0006490 | Process | oligosaccharide-lipid intermediate assembly |
| GO:0006487 | Process | protein amino acid N-linked glycosylation |
Gene Interactions
[
] BioGRID Gene Product Interaction Database
| Symbol | Interaction Binary | Experiment | Source |
|---|---|---|---|
| ALG6 | ALG6 / ALG8 | Phenotypic Enhancement | Schuldiner M (2005) |
| ALG6 | ALG8 / ALG6 | Phenotypic Enhancement | Schuldiner M (2005) |
| APL5 | ALG8 / APL5 | Phenotypic Enhancement | Schuldiner M (2005) |
| APL5 | APL5 / ALG8 | Phenotypic Enhancement | Schuldiner M (2005) |
| BCK1 | ALG8 / BCK1 | Synthetic Lethality | Tong AH (2004) |
| BIG1 | ALG8 / BIG1 | Phenotypic Enhancement | Schuldiner M (2005) |
| BIG1 | BIG1 / ALG8 | Phenotypic Enhancement | Schuldiner M (2005) |
| BST1 | ALG8 / BST1 | Phenotypic Enhancement | Schuldiner M (2005) |
| CHO2 | ALG8 / CHO2 | Phenotypic Suppression | Schuldiner M (2005) |
| CPT1 | CPT1 / ALG8 | Two-hybrid | Miller JP (2005) |
| CSF1 | ALG8 / CSF1 | Synthetic Lethality | Tong AH (2004) |
| CWH41 | CWH41 / ALG8 | Phenotypic Suppression | Runge KW (1986) |
| DIA2 | ALG8 / DIA2 | Synthetic Lethality | Tong AH (2004) |
| ESA1 | ESA1 / ALG8 | Synthetic Growth Defect | Lin YY (2008) |
| GAS1 | ALG8 / GAS1 | Phenotypic Enhancement | Schuldiner M (2005) |
| GAS1 | GAS1 / ALG8 | Phenotypic Enhancement | Schuldiner M (2005) |
| GDA1 | ALG8 / GDA1 | Phenotypic Enhancement | Schuldiner M (2005) |
| GDA1 | GDA1 / ALG8 | Phenotypic Enhancement | Schuldiner M (2005) |
| GOS1 | ALG8 / GOS1 | Phenotypic Enhancement | Schuldiner M (2005) |
| GOS1 | GOS1 / ALG8 | Phenotypic Enhancement | Schuldiner M (2005) |
| GSG1 | ALG8 / GSG1 | Phenotypic Suppression | Schuldiner M (2005) |
| GUP1 | ALG8 / GUP1 | Phenotypic Enhancement | Schuldiner M (2005) |
| GUP1 | GUP1 / ALG8 | Phenotypic Enhancement | Schuldiner M (2005) |
| HAC1 | ALG8 / HAC1 | Phenotypic Enhancement | Schuldiner M (2005) |
| HSD1 | ALG8 / HSD1 | Phenotypic Enhancement | Schuldiner M (2005) |
| HSD1 | HSD1 / ALG8 | Phenotypic Enhancement | Schuldiner M (2005) |
| IRE1 | ALG8 / IRE1 | Phenotypic Enhancement | Schuldiner M (2005) |
| IRE1 | IRE1 / ALG8 | Phenotypic Enhancement | Schuldiner M (2005) |
| KEX1 | ALG8 / KEX1 | Phenotypic Enhancement | Schuldiner M (2005) |
| LAS21 | ALG8 / LAS21 | Phenotypic Enhancement | Schuldiner M (2005) |
| MDM39 | MDM39 / ALG8 | Synthetic Growth Defect | Pan X (2006) |
| MGA2 | ALG8 / MGA2 | Phenotypic Suppression | Schuldiner M (2005) |
| MGA2 | MGA2 / ALG8 | Phenotypic Suppression | Schuldiner M (2005) |
| N/A | ALG8 / N/A | Phenotypic Enhancement | Schuldiner M (2005) |
| N/A | N/A / ALG8 | Phenotypic Enhancement | Schuldiner M (2005) |
| N/A | ALG8 / N/A | Phenotypic Suppression | Schuldiner M (2005) |
| OLE1 | ALG8 / OLE1 | Phenotypic Suppression | Schuldiner M (2005) |
| OPI3 | ALG8 / OPI3 | Phenotypic Enhancement | Schuldiner M (2005) |
| OST1 | ALG8 / OST1 | Phenotypic Enhancement | Schuldiner M (2005) |
| OST3 | ALG8 / OST3 | Synthetic Lethality | Tong AH (2004) |
| OST5 | ALG8 / OST5 | Phenotypic Enhancement | Schuldiner M (2005) |
| OST5 | OST5 / ALG8 | Phenotypic Enhancement | Schuldiner M (2005) |
| OST5 | ALG8 / OST5 | Synthetic Lethality | Tong AH (2004) |
| OST6 | ALG8 / OST6 | Phenotypic Enhancement | Schuldiner M (2005) |
| OST6 | OST6 / ALG8 | Phenotypic Enhancement | Schuldiner M (2005) |
| PER1 | ALG8 / PER1 | Synthetic Lethality | Tong AH (2004) |
| PMA1 | PMA1 / ALG8 | Synthetic Rescue | Luo W (1997) |
| PMR1 | ALG8 / PMR1 | Phenotypic Enhancement | Schuldiner M (2005) |
| PMR1 | PMR1 / ALG8 | Phenotypic Enhancement | Schuldiner M (2005) |
| PMT4 | ALG8 / PMT4 | Phenotypic Suppression | Schuldiner M (2005) |
| RMD7 | ALG8 / RMD7 | Phenotypic Enhancement | Schuldiner M (2005) |
| RMD7 | RMD7 / ALG8 | Phenotypic Enhancement | Schuldiner M (2005) |
| RMD7 | RMD7 / ALG8 | Synthetic Growth Defect | Pan X (2006) |
| RPO41 | ALG8 / RPO41 | Synthetic Lethality | Tong AH (2004) |
| SEC66 | ALG8 / SEC66 | Phenotypic Enhancement | Schuldiner M (2005) |
| SEC66 | SEC66 / ALG8 | Phenotypic Enhancement | Schuldiner M (2005) |
| SEL1 | ALG8 / SEL1 | Phenotypic Suppression | Schuldiner M (2005) |
| SHE4 | ALG8 / SHE4 | Synthetic Lethality | Tong AH (2004) |
| SHR3 | ALG8 / SHR3 | Phenotypic Suppression | Schuldiner M (2005) |
| SHR3 | SHR3 / ALG8 | Phenotypic Suppression | Schuldiner M (2005) |
| SLT2 | ALG8 / SLT2 | Synthetic Lethality | Tong AH (2004) |
| SUR2 | ALG8 / SUR2 | Phenotypic Enhancement | Schuldiner M (2005) |
| SUR2 | SUR2 / ALG8 | Phenotypic Enhancement | Schuldiner M (2005) |
| SWA2 | ALG8 / SWA2 | Phenotypic Enhancement | Schuldiner M (2005) |
| TPS2 | ALG8 / TPS2 | Synthetic Lethality | Tong AH (2004) |
| WBP1 | ALG8 / WBP1 | Phenotypic Enhancement | Schuldiner M (2005) |
| WBP1 | WBP1 / ALG8 | Phenotypic Enhancement | Stagljar I (1994) |
| WBP1 | ALG8 / WBP1 | Synthetic Growth Defect | Stagljar I (1994) |
Selected Publications
[
] Gene-related publications indexed at PubMed
- [
] Huttenhower C, et al. (2008) "Assessing the functional structure of genomic data." Bioinformatics. 24(13):i330-i338. PMID:18586732 - [
] Pan X, et al. (2006) "A DNA integrity network in the yeast Saccharomyces cerevisiae." Cell. 124(5):1069-1081. PMID:16487579 - [
] Miller JP, et al. (2005) "Large-scale identification of yeast integral membrane protein interactions." Proc Natl Acad Sci U S A. 102(34):12123-12128. PMID:16093310 - [
] Schuldiner M, et al. (2005) "Exploration of the function and organization of the yeast early secretory pathway through an epistatic miniarray profile." Cell. 123(3):507-519. PMID:16269340 - [
] Tong AH, et al. (2004) "Global mapping of the yeast genetic interaction network." Science. 303(5659):808-813. PMID:14764870 - [
] Dujon B, et al. (1997) "The nucleotide sequence of Saccharomyces cerevisiae chromosome XV." Nature. 387(6632 Suppl):98-102. PMID:9169874 - [
] Luo W, et al. (1997) "Novel genes involved in endosomal traffic in yeast revealed by suppression of a targeting-defective plasma membrane ATPase mutant." J Cell Biol. 138(4):731-746. PMID:9265642 - [
] Goffeau A, et al. (1996) "Life with 6000 genes." Science. 274(5287):546, 563-546, 567. PMID:8849441 - [
] Stagljar I, et al. (1994) "New phenotype of mutations deficient in glucosylation of the lipid-linked oligosaccharide: cloning of the ALG8 locus." Proc Natl Acad Sci U S A. 91(13):5977-5981. PMID:8016100 - [
] Runge KW, et al. (1986) "A new yeast mutation in the glucosylation steps of the asparagine-linked glycosylation pathway. Formation of a novel asparagine-linked oligosaccharide containing two glucose residues." J Biol Chem. 261(33):15582-15590. PMID:3536907
MOTIVATION: The availability of genome-scale data has enabled an abundance of novel analysis techniques for investigating a variety of systems-level biological relationships. As thousands of such datasets become available, they provide an opportunity to study high-level associations between cellular pathways and processes. This also allows the exploration of shared functional enrichments between diverse biological datasets, and it serves to direct experimenters to areas of low data coverage or with high probability of new discoveries. RESULTS: We analyze the functional structure of Saccharomyces cerevisiae datasets from over 950 publications in the context of over 140 biological processes. This includes a coverage analysis of biological processes given current high-throughput data, a data-driven map of associations between processes, and a measure of similar functional activity between genome-scale datasets. This uncovers subtle gene expression similarities in three otherwise disparate microarray datasets due to a shared strain background. We also provide several means of predicting areas of yeast biology likely to benefit from additional high-throughput experimental screens. AVAILABILITY: Predictions are provided in supplementary tables; software and additional data are available from the authors by request. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online.
A network governing DNA integrity was identified in yeast by a global genetic analysis of synthetic fitness or lethality defect (SFL) interactions. Within this network, 16 functional modules or minipathways were defined based on patterns of global SFL interactions. Modules or genes involved in DNA replication, DNA-replication checkpoint (DRC) signaling, and oxidative stress response were identified as the major guardians against lethal spontaneous DNA damage, efficient repair of which requires the functions of the DNA-damage checkpoint signaling and multiple DNA-repair pathways. This genome-wide genetic interaction network also identified novel components (DIA2, NPT1, HST3, HST4, and the CSM1 module) that potentially contribute to mitotic DNA replication and genomic stability and revealed novel functions of well-studied genes (the CTF18 module) in DRC signaling. This network will guide more detailed characterization of mechanisms governing DNA integrity in yeast and other organisms.
We carried out a large-scale screen to identify interactions between integral membrane proteins of Saccharomyces cerevisiae by using a modified split-ubiquitin technique. Among 705 proteins annotated as integral membrane, we identified 1,985 putative interactions involving 536 proteins. To ascribe confidence levels to the interactions, we used a support vector machine algorithm to classify interactions based on the assay results and protein data derived from the literature. Previously identified and computationally supported interactions were used to train the support vector machine, which identified 131 interactions of highest confidence, 209 of the next highest confidence, 468 of the next highest, and the remaining 1,085 of low confidence. This study provides numerous putative interactions among a class of proteins that have been difficult to analyze on a high-throughput basis by other approaches. The results identify potential previously undescribed components of established biological processes and roles for integral membrane proteins of ascribed functions.
We present a strategy for generating and analyzing comprehensive genetic-interaction maps, termed E-MAPs (epistatic miniarray profiles), comprising quantitative measures of aggravating or alleviating interactions between gene pairs. Crucial to the interpretation of E-MAPs is their high-density nature made possible by focusing on logically connected gene subsets and including essential genes. Described here is the analysis of an E-MAP of genes acting in the yeast early secretory pathway. Hierarchical clustering, together with novel analytical strategies and experimental verification, revealed or clarified the role of many proteins involved in extensively studied processes such as sphingolipid metabolism and retention of HDEL proteins. At a broader level, analysis of the E-MAP delineated pathway organization and components of physical complexes and illustrated the interconnection between the various secretory processes. Extension of this strategy to other logically connected gene subsets in yeast and higher eukaryotes should provide critical insights into the functional/organizational principles of biological systems.
A genetic interaction network containing approximately 1000 genes and approximately 4000 interactions was mapped by crossing mutations in 132 different query genes into a set of approximately 4700 viable gene yeast deletion mutants and scoring the double mutant progeny for fitness defects. Network connectivity was predictive of function because interactions often occurred among functionally related genes, and similar patterns of interactions tended to identify components of the same pathway. The genetic network exhibited dense local neighborhoods; therefore, the position of a gene on a partially mapped network is predictive of other genetic interactions. Because digenic interactions are common in yeast, similar networks may underlie the complex genetics associated with inherited phenotypes in other organisms.
Chromosome XV was one of the last two chromosomes of Saccharomyces cerevisiae to be discovered. It is the third-largest yeast chromosome after chromosomes XII and IV, and is very similar in size to chromosome VII. It alone represents 9% of the yeast genome (8% if ribosomal DNA is included). When systematic sequencing of chromosome XV was started, 93 genes or markers were identified, and most of them were mapped. However, very little else was known about chromosome XV which, in contrast to shorter chromosomes, had not been the object of comprehensive genetic or molecular analysis. It was therefore decided to start sequencing chromosome XV only in the third phase of the European Yeast Genome Sequencing Programme, after experience was gained on chromosomes III, XI and II. The sequence of chromosome XV has been determined from a set of partly overlapping cosmid clones derived from a unique yeast strain, and physically mapped at 3.3-kilobase resolution before sequencing. As well as numerous new open reading frames (ORFs) and genes encoding tRNA or small RNA molecules, the sequence of 1,091,283 base pairs confirms the high proportion of orphan genes and reveals a number of ancestral and successive duplications with other yeast chromosomes.
A novel genetic selection was used to identify genes regulating traffic in the yeast endosomal system. We took advantage of a temperature-sensitive mutant in PMA1, encoding the plasma membrane ATPase, in which newly synthesized Pma1 is mislocalized to the vacuole via the endosome. Diversion of mutant Pma1 from vacuolar delivery and rerouting to the plasma membrane is a major mechanism of suppression of pma1(ts). 16 independent suppressor of pma1 (sop) mutants were isolated. Identification of the corresponding genes reveals eight that are identical with VPS genes required for delivery of newly synthesized vacuolar proteins. A second group of SOP genes participates in vacuolar delivery of mutant Pma1 but is not essential for delivery of the vacuolar protease carboxypeptidase Y. Because the biosynthetic pathway to the vacuole intersects with the endocytic pathway, internalization of a bulk membrane endocytic marker FM 4-64 was assayed in the sop mutants. By this means, defective endosome-to-vacuole trafficking was revealed in a subset of sop mutants. Another subset of sop mutants displays perturbed trafficking between endosome and Golgi: impaired pro-alpha factor processing in these strains was found to be due to defective recycling of the trans-Golgi protease Kex2. One of these strains defective in Kex2 trafficking carries a mutation in SOP2, encoding a homologue of mammalian synaptojanin (implicated in synaptic vesicle endocytosis and recycling). Thus, cell surface delivery of mutant Pma1 can occur as a consequence of disturbances at several different sites in the endosomal system.
The genome of the yeast Saccharomyces cerevisiae has been completely sequenced through a worldwide collaboration. The sequence of 12,068 kilobases defines 5885 potential protein-encoding genes, approximately 140 genes specifying ribosomal RNA, 40 genes for small nuclear RNA molecules, and 275 transfer RNA genes. In addition, the complete sequence provides information about the higher order organization of yeast's 16 chromosomes and allows some insight into their evolutionary history. The genome shows a considerable amount of apparent genetic redundancy, and one of the major problems to be tackled during the next stage of the yeast genome project is to elucidate the biological functions of all of these genes.
Glc3Man9GlcNAc2 is the preferred substrate of the oligosaccharyltransferase of N-linked glycosylation of proteins, but nonglucosylated oligosaccharides can be transferred to proteins in Saccharomyces cerevisiae. Mutations affecting the addition of the three terminal glucose residues lead to accumulation of Man9GlcNAc2 or Glc1Man9GlcNAc2 in vivo but do not show any detectable growth defect. When these mutations were introduced into a strain with reduced oligosaccharyltransferase activity (due to the wbp1-1 mutation), a severe growth defect was observed: accumulation of suboptimal lipid-linked oligosaccharide and reduced oligosaccharyltransferase activity resulted in a severe underglycosylation of secreted proteins. This new synthetic phenotype made it possible to isolate the ALG8 locus, encoding a potential glucosyltransferase of the endoplasmic reticulum. The ALG8 protein is a 63.5-kDa hydrophobic protein that is not essential for the vegetative growth of yeast. However, the lack of this protein resulted in underglycosylation of secreted proteins.
We have isolated and characterized a new yeast mutation in the glucosylation steps of lipid-linked oligosaccharide biosynthesis, alg8-1. Cells carrying the alg8-1 mutation accumulate Glc1Man9GlcNAc2-lipid both in vivo and in vitro. We present evidence showing that the alg8-1 mutation blocks addition of the second alpha 1,3-linked glucose. alg8-1 cells transfer Glc1Man9GlcNAc2 to protein instead of the wild type oligosaccharide, Glc3Man9GlcNAc2. Pulse-chase studies indicate that the Glc1Man9GlcNAc2 transferred is processed more slowly than the wild type oligosaccharide. The yeast mutation gls1-1 lacks glucosidase I activity (Esmon, B., Esmon, P.C., and Schekman, R. (1984) J. Biol. Chem. 259, 10322-10327), the enzyme responsible for removing the alpha 1,2-linked glucose residues from protein-linked oligosaccharides. We demonstrate that gls1-1 cells contain glucosidase II activity (which removes alpha 1,3-linked glucose residues) and have constructed the alg8-1 gls1-1 haploid double mutant. The Glc1Man9GlcNAc2 oligosaccharide was trimmed normally in these cells, demonstrating that the alg8-1 oligosaccharide contained an alpha 1,3-linked glucose residue. A novel Glc2 compound was probably produced by the action of the biosynthetic enzyme that normally adds the alpha 1,2-linked glucose to lipid-linked Glc2Man9GlcNAc2. This enzyme may be able to slowly add alpha 1,2-linked glucose residue to protein-bound Glc1Man9GlcNAc2. The relevance of these findings to similar observations in other systems where glucose residues are added to asparagine-linked oligosaccharides and the possible significance of the reduced rate of oligosaccharide trimming in the alg mutants are discussed.